Gene: CHFR
Official Full Name: checkpoint with forkhead and ring finger domainsprovided by HGNC
Gene Summary: This gene encodes an E3 ubiquitin-protein ligase required for the maintenance of the antephase checkpoint that regulates cell cycle entry into mitosis and, therefore, may play a key role in cell cycle progression and tumorigenesis. The encoded protein has an N-terminal forkhead-associated domain, a central RING-finger domain, and a cysteine-rich C-terminal region. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Mar 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18728 | CHFR Knockout cell line (HeLa) | Human | CHFR | 1:3~1:6 | Negative | Online Inquiry |
KO18729 | CHFR Knockout cell line (HEK293) | Human | CHFR | 1:3~1:6 | Negative | Online Inquiry |
KO18730 | CHFR Knockout cell line (A549) | Human | CHFR | 1:3~1:4 | Negative | Online Inquiry |
CHFR Gene Knockout Cell Lines are genetically engineered cell lines in which the CHFR gene has been selectively disrupted, allowing researchers to study the gene's role in cellular processes more effectively. CHFR (Checkpoint with Forkhead and Ring finger) is known to regulate the cellular response to stress and is implicated in various stages of the cell cycle, particularly in mitotic checkpoints. By providing a model for the loss of CHFR function, these knockout cell lines enable a deeper investigation into mechanisms of genomic stability, tumorigenesis, and resistance to chemotherapeutic agents.
The key function of CHFR is its involvement in the monitoring of DNA integrity and the induction of cellular arrest in response to damage. Understanding how the knockout of this gene affects cellular behavior is crucial for researchers studying cancer biology, as many tumors demonstrate dysregulation of cell cycle control mechanisms. The CHFR Gene Knockout Cell Lines allow for the examination of proliferation rates, genomic instability, and the cellular response to DNA-damaging agents, thereby providing critical insights into the mechanisms driving oncogenic transformation.
In scientific research and clinical settings, these cell lines offer significant advantages. They serve as vital tools for drug screening, biomarker discovery, and therapeutic development. Unlike alternatives that rely on transient knockdown techniques, the stable knockout provided by these cell lines allows for consistent and reproducible results, making them indispensable for long-term studies.
For researchers or clinicians focused on cancer research, the ability to study cells lacking CHFR function can yield transformative findings in drug resistance and tumor behavior, thus paving the way for novel therapeutic strategies. Our commitment to advancing biological research through innovative products is demonstrated by our extensive portfolio that includes these specialized cell lines. We leverage cutting-edge technologies and expert knowledge to ensure researchers have the tools necessary to drive their discoveries forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.